• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

难治性子宫内膜的管理策略:2016年的最新进展

Strategies to manage refractory endometrium: state of the art in 2016.

作者信息

Garcia-Velasco Juan A, Acevedo Belen, Alvarez Claudio, Alvarez Monica, Bellver Jose, Fontes Juan, Landeras Jose, Manau Dolors, Martinez Francisca, Muñoz Elkin, Robles Ana, Rodriguez-Tabernero Luis

机构信息

IVI-Madrid, Rey Juan Carlos University, Madrid, Spain.

Fundación Jiménez Díaz, Madrid, Spain.

出版信息

Reprod Biomed Online. 2016 May;32(5):474-89. doi: 10.1016/j.rbmo.2016.02.001. Epub 2016 Feb 23.

DOI:10.1016/j.rbmo.2016.02.001
PMID:26947451
Abstract

The endometrium is one of a number of factors involved in achieving optimal outcomes after assisted reproductive treatment. Owing to its "passive" growth following adequate ovarian stimulation, it has received virtually no attention. Only when either endometrial thickness or ultrasonographic pattern seem inadequate have different strategies been assessed to try to improve it, especially in those cases where it seems difficult or impossible to make it grow. The objective of this review is to summarize the different strategies that have been investigated in patients with inadequate endometrium, to attempt to provide solid evidence of therapies that may be beneficial and to move away from empirism. A review of the existing literature was performed by searching MEDLINE, EMBASE, Cochrane library and Web of Science for publications in English related to refractory endometrium. Most current treatments are based on anecdotal cases and not on solid data, although worldwide many doctors and patients use them. In conclusion, this review found that it is not easy to provide a pragmatic, evidence-based approach to help physicians and patients confused by the available data on how to improve a poor endometrium. Honest balanced information provided to our patients is the best that we can do.

摘要

子宫内膜是辅助生殖治疗后实现最佳结局所涉及的诸多因素之一。由于其在充分的卵巢刺激后呈“被动”生长,实际上一直未受到关注。只有当子宫内膜厚度或超声图像看起来不充分时,才会评估不同的策略来试图改善它,特别是在那些内膜似乎难以生长或无法生长的情况下。本综述的目的是总结针对子宫内膜不充分的患者所研究的不同策略,试图为可能有益的治疗方法提供确凿证据,并摆脱经验主义。通过检索MEDLINE、EMBASE、Cochrane图书馆和科学网,对现有文献进行了回顾,以查找与难治性子宫内膜相关的英文出版物。尽管全球许多医生和患者都在使用,但目前大多数治疗方法都基于个别案例,而非确凿数据。总之,本综述发现,要提供一种实用的、基于证据的方法来帮助被现有关于如何改善薄型子宫内膜的数据所困扰的医生和患者并非易事。向我们的患者提供诚实、平衡的信息是我们所能做的最好的事情。

相似文献

1
Strategies to manage refractory endometrium: state of the art in 2016.难治性子宫内膜的管理策略:2016年的最新进展
Reprod Biomed Online. 2016 May;32(5):474-89. doi: 10.1016/j.rbmo.2016.02.001. Epub 2016 Feb 23.
2
Management of thin endometrium in assisted reproduction: a clinical practice guideline from the Canadian Fertility and Andrology Society.辅助生殖中薄型子宫内膜的管理:来自加拿大生育与男科协会的临床实践指南。
Reprod Biomed Online. 2019 Jul;39(1):49-62. doi: 10.1016/j.rbmo.2019.02.013. Epub 2019 Mar 20.
3
Thin endometrium in assisted reproductive technology.辅助生殖技术中的薄子宫内膜。
Curr Opin Obstet Gynecol. 2008 Jun;20(3):221-8. doi: 10.1097/GCO.0b013e328302143c.
4
ART and uterine pathology: how relevant is the maternal side for implantation?ART 与子宫病理学:母体方面与着床的相关性如何?
Hum Reprod Update. 2015 Jan-Feb;21(1):13-38. doi: 10.1093/humupd/dmu047. Epub 2014 Aug 25.
5
Treating patients with "thin" endometrium - an ongoing challenge.治疗子宫内膜“薄”的患者——一项持续存在的挑战。
Gynecol Endocrinol. 2014 Jun;30(6):409-14. doi: 10.3109/09513590.2014.906571. Epub 2014 Apr 2.
6
A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies.粒细胞集落刺激因子治疗标准治疗反应不佳的薄型子宫内膜的初步队列研究。
Hum Reprod. 2013 Jan;28(1):172-7. doi: 10.1093/humrep/des370. Epub 2012 Oct 18.
7
A simulation of gas-based, endometrial-ablation therapy.基于气体的子宫内膜消融治疗模拟。
Ann Biomed Eng. 2008 Jan;36(1):171-83. doi: 10.1007/s10439-007-9388-5. Epub 2007 Oct 13.
8
Pipelle for Pregnancy (PIP): study protocols for three randomised controlled trials.妊娠用 Pipelle 取样器(PIP):三项随机对照试验的研究方案
Trials. 2016 Apr 27;17(1):216. doi: 10.1186/s13063-016-1301-9.
9
Risk of placenta praevia is linked to endometrial thickness in a retrospective cohort study of 4537 singleton assisted reproduction technology births.在一项针对4537例单胎辅助生殖技术分娩的回顾性队列研究中,前置胎盘风险与子宫内膜厚度有关。
Hum Reprod. 2014 Dec;29(12):2787-93. doi: 10.1093/humrep/deu240. Epub 2014 Sep 19.
10
The use of a combination of pentoxifylline and tocopherol in women with a thin endometrium undergoing assisted conception therapies--a report of 20 cases.己酮可可碱与生育三烯酚联合应用于子宫内膜薄的接受辅助生殖治疗的女性——20例报告
Hum Fertil (Camb). 2009 Dec;12(4):198-203. doi: 10.3109/14647270903377178.

引用本文的文献

1
Platelet-rich plasma therapy for thin endometrium: a comprehensive review.富血小板血浆疗法治疗薄型子宫内膜:一项综述
Arch Gynecol Obstet. 2025 Jun 12. doi: 10.1007/s00404-025-08077-5.
2
Endometrial Infusion with Plasma Rich in Growth Factors (PRGF) in IVF Cycles: Randomized Clinical Trial in Very Thin Endometrium and Observational Uncontrolled Follow-Up After the Randomized Clinical Trial.体外受精周期中子宫内膜输注富含生长因子的血浆(PRGF):极薄子宫内膜的随机临床试验及随机临床试验后的非对照观察随访
J Clin Med. 2025 Mar 13;14(6):1952. doi: 10.3390/jcm14061952.
3
Evolution of biotechnological advances and regenerative therapies for endometrial disorders: a systematic review.
生物技术进展与子宫内膜疾病再生疗法的演变:系统评价。
Hum Reprod Update. 2024 Oct 1;30(5):584-613. doi: 10.1093/humupd/dmae013.
4
Effectiveness of Autologous Platelet-Rich Plasma Therapy in Women with Repeated Implantation Failure: A Randomized Clinical Trial.自体富血小板血浆疗法对反复种植失败女性的有效性:一项随机临床试验。
Int J Fertil Steril. 2024 Feb 2;18(2):162-166. doi: 10.22074/ijfs.2023.553636.1305.
5
Factors Affecting the Potential Efficacy of Intrauterine Platelet-Rich Plasma Infusion on Thin Endometrium in Women with Recurrent Implantation Failure.影响宫腔内输注富血小板血浆对复发性植入失败女性薄子宫内膜潜在疗效的因素。
J Pers Med. 2023 Sep 21;13(9):1419. doi: 10.3390/jpm13091419.
6
Intrauterine instillation of autologous platelet-rich plasma in infertile females with thin endometrium undergoing intrauterine insemination: an open-label randomized controlled trial.对接受宫腔内人工授精的子宫内膜薄的不孕女性进行宫腔内自体富血小板血浆灌注:一项开放标签随机对照试验。
AJOG Glob Rep. 2023 Feb 9;3(2):100172. doi: 10.1016/j.xagr.2023.100172. eCollection 2023 May.
7
Growth Hormone: A Potential Treatment of Patients with Refractory Thin Endometrium: A Clinical Trial Study.生长激素:难治性薄型子宫内膜患者的一种潜在治疗方法:一项临床试验研究
Int J Fertil Steril. 2022 Oct 9;16(4):251-255. doi: 10.22074/ijfs.2022.541389.1210.
8
Endometrial preservation during resection of type II and type III submucosal fibroids.II型和III型黏膜下肌瘤切除术中的子宫内膜保留
Facts Views Vis Obgyn. 2022 Sep;14(3):283-285. doi: 10.52054/FVVO.14.3.038.
9
Evaluation of the effect of intrauterine injection of platelet-rich plasma on the pregnancy rate of patients with a history of implantation failure in the fertilization cycle.评估宫腔注射富血小板血浆对受精周期中既往有种植失败史患者妊娠率的影响。
J Family Med Prim Care. 2022 May;11(5):2162-2166. doi: 10.4103/jfmpc.jfmpc_1817_21. Epub 2022 May 14.
10
A Novel Xeno-Free Method to Isolate Human Endometrial Mesenchymal Stromal Cells (E-MSCs) in Good Manufacturing Practice (GMP) Conditions.一种新型无动物源的方法,用于在良好生产规范(GMP)条件下分离人子宫内膜间充质基质细胞(E-MSCs)。
Int J Mol Sci. 2022 Feb 9;23(4):1931. doi: 10.3390/ijms23041931.